Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-20

FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Lithium carbonate ER submitted by Glenmark Pharmaceuticals Inc., USA, representing an approved change to an existing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate ER (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)